FDA “Breakthrough Therapy” Designations
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Breakthrough status was introduced in FDASIA to facilitate development and review of drugs to treat serious/life-threatening diseases where there is early evidence of a substantial improvement over existing therapies.